Mana.bio logo

Mana.bio Funding & Investors

Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.

mana.bio

Total Amount Raised: $24,500,000

Mana.bio Funding Rounds

  • Seed

    $19,500,000

    Seed Investors

    Andreessen Horowitz
    Base4 Capital
    LionBird (ventures)
    NFX
    Technion - Israel Institute of Technology
  • Seed

    $5,000,000

    Seed Investors

    NFX
Funding info provided by Diffbot.